CompoAtlas

Ganmao Qingre Granule

Natural health product licensed in Canada

Licence holder
T.C. Unicorn Ltd.
NPN or DIN-HM
80016308
Status
Active licence
Licence date
2 March 2010
Revision date
Not provided
Form
Granules
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phragmites communis

Source : Rhizome

Extraction ratio : 6.7:1

Dry plant equivalent : 1,200 mg

180 mgNot calculated
Bupleurum chinense

Source : Racine

Extraction ratio : 6.7:1

Dry plant equivalent : 750 mg

113 mgNot calculated
Mentha haplocalyx

Extraction ratio : 6.7:1

Dry plant equivalent : 450 mg

68 mgNot calculated
Schizonepeta tenuifolia

Source : Fringe

Extraction ratio : 6.7:1

Dry plant equivalent : 1,500 mg

224 mgNot calculated

Non-medicinal ingredients

Lactose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 packet2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Traditional Chinese medicine that helps dispel wind-cold, induce diaphoresis and remove heat. It is used for colds with headache, fever, chills general aching, stuffed running nose, cough and dryness of the throat.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80016308

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line